Prioriteit geven aan doelgedrag voor onderzoek bij diabetes: de nominale groepstechniek gebruiken om consensus te bereiken van de belangrijkste belanghebbenden.
NIET TOEGEWEZEN Het gedrag van personen met diabetes (bijv. behandeling) en het gedrag van artsen en verschillende beroepsbeoefenaren in de gezondheidszorg (bijv. controle van de bloedsuikerspiegel van patiënten) zijn essentieel.
Onze onderzoeksgroep moest één gedrag van betrokkenen en één gedrag van bekwame zorgverleners kiezen als proefpersonen in Ierland. Patiënten en beroepsbeoefenaren in de gezondheidszorg worden meestal niet vaak gevraagd om te helpen bij het oplossen van onderzoeksonderwerpen.
In dit onderzoek moesten we collectief patiënten, zorgverleners en dekkingsmakers overbrengen om ons te helpen bij het oplossen van het meest essentiële doelgedrag voor onderzoek naar diabetes in Ierland. We werkten met 24 medewerkers, samen met mensen met diabetes, diabetesprofessionals en dekkingsmakers.
Ten eerste gaven de bijdragers instructies over gedragingen waarvan zij dachten dat ze essentieel waren voor onderzoek naar diabetes. Deelnemers woonden vervolgens een bijeenkomst bij en beoordeelden welk van de gedragingen het meest essentieel waren en noemden de resultaten van de ranglijst als een groep. We herkenden het meest extreem gerangschikte gedrag van getroffen personen en zorgverleners.
Het belangrijkste gerangschikte gedrag voor mensen met diabetes type 1 was ‘insuline nemen zoals vereist’ en voor mensen met diabetes type 2 was ‘het bijwonen van en interactie hebben met gestructureerde scholingsprogramma’s’. ‘Betrokkenheid bij het stellen van samenwerkingsdoelen met patiënten’ was het belangrijkste gedrag van zorgprofessionals.
Uit ons onderzoek blijkt dat het voor onderzoekers goed te doen is om samen te werken met mensen met diabetes, beroepsbeoefenaren in de gezondheidszorg en makers van dekkingen om onderzoeksonderwerpen op te lossen. De eerst gerangschikte gedragingen zullen nu worden onderzocht door onze groep in Ierland. UNASSIGNED Achtergrond Werken met patiënten, zorgverleners en dekkingsmakers om prioriteit te geven aan onderzoek onderwerpen kunnen de relevantie van onderzoek verbeteren en de kans vergroten dat onderzoeksresultaten worden omgezet in waarneming.
Het doel van het huidige onderzoek was om samen te werken met de belangrijkste belanghebbenden om te bepalen en consensus te bereiken over het meest essentiële doelgedrag voor onderzoek naar diabetes in Ierland. Methoden Vierentwintig bijdragers, samen met mensen met diabetes, diabetesprofessionals en dekkingsmakers, namen de helft in een nominale consensuscursus voor groepstechnieken.
Via een webgebaseerde enquête genereerden de bijdragers lijsten van essentieel doelgedrag op drie gebieden: diabetes type 1 beheren, diabetes type 2 beheren en diabetes type 2 stoppen.

Deelnemers woonden vervolgens een onderzoeksprioriteringsassemblage bij en rangschikten doelgedrag in twee rondes, met een groepsdialoog tussen beoordelingsrondes. Voor elk van de drie belangrijkste gebieden hadden de zes eerst gerangschikte gedragingen betrekking op mensen met diabetes en beroepsbeoefenaren in de gezondheidszorg zijn erkend.
Resultaten In de meeste gevallen was het meest extreem gerangschikte gedrag vergelijkbaar voor rangorde 1 en rangschikking 2 en was er een grotere consensus met betrekking tot het onderschrijven van eersteklas gedrag. Sommige gedragingen veranderden echter van plaats tussen ranglijsten.
CD339 Blocking Peptide |
|||
33R-10635 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD339 antibody, catalog no. 70R-11614 |
PKA Blocking Peptide |
|||
33R-10637 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PKA antibody, catalog no. 70R-11621 |
Raf1 Blocking Peptide |
|||
33R-10638 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Raf1 antibody, catalog no. 70R-11622 |
Wee1 Blocking Peptide |
|||
33R-10639 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Wee1 antibody, catalog no. 70R-11626 |
IHH Blocking Peptide |
|||
33R-1064 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SLC26A1 antibody, catalog no. 70R-6562 |
GSTP1 Blocking Peptide |
|||
33R-10640 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GSTP1 antibody, catalog no. 70R-11628 |
TNFR1 Blocking Peptide |
|||
33R-10641 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TNFR1 antibody, catalog no. 70R-11629 |
LSD1 Blocking Peptide |
|||
33R-10642 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LSD1 antibody, catalog no. 70R-11631 |
STAT1 Blocking Peptide |
|||
33R-10643 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of STAT1 antibody, catalog no. 70R-11633 |
MAK10 Blocking Peptide |
|||
33R-10644 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MAK10 antibody, catalog no. 70R-11634 |
ACADM Blocking Peptide |
|||
33R-10647 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADM antibody, catalog no. 70R-11637 |
ACADL Blocking Peptide |
|||
33R-10649 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADL antibody, catalog no. 70R-11639 |
SLC26A1 Blocking Peptide |
|||
33R-1065 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody, catalog no. 70R-1508 |
ACADSB Blocking Peptide |
|||
33R-10650 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADSB antibody, catalog no. 70R-11649 |
ACADSB Blocking Peptide |
|||
33R-10651 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADSB antibody, catalog no. 70R-11656 |
Survivin Blocking Peptide |
|||
33R-10653 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Survivin antibody, catalog no. 70R-11659 |
Bid Blocking Peptide |
|||
33R-10654 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Bid antibody, catalog no. 70R-11670 |
CD40L Blocking Peptide |
|||
33R-10655 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD40L antibody, catalog no. 70R-11674 |
cIAP1 Blocking Peptide |
|||
33R-10656 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP1 antibody, catalog no. 70R-11676 |
cIAP1 Blocking Peptide |
|||
33R-10657 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP1 antibody, catalog no. 70R-11675 |
cIAP2 Blocking Peptide |
|||
33R-10658 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP2 antibody, catalog no. 70R-11677 |
XIAP Blocking Peptide |
|||
33R-10659 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of XIAP antibody, catalog no. 70R-11678 |
CACNB2 Blocking Peptide |
|||
33R-1066 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LHPP antibody, catalog no. 70R-4027 |
Perforin Blocking Peptide |
|||
33R-10660 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Perforin antibody, catalog no. 70R-11680 |
NIK Blocking Peptide |
|||
33R-10665 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NIK antibody, catalog no. 70R-11685 |
TrkA Blocking Peptide |
|||
33R-10666 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TrkA antibody, catalog no. 70R-11686 |
AIF Blocking Peptide |
|||
33R-10667 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of AIF antibody, catalog no. 70R-11690 |
DR6 Blocking Peptide |
|||
33R-10668 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DR6 antibody, catalog no. 70R-11695 |
SIRT3 Blocking Peptide |
|||
33R-10669 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIRT3 antibody, catalog no. 70R-11698 |
LHPP Blocking Peptide |
|||
33R-1067 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of UPP1 antibody, catalog no. 70R-3171 |
SIRT4 Blocking Peptide |
|||
33R-10670 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIRT4 antibody, catalog no. 70R-11699 |
SIRT5 Blocking Peptide |
|||
33R-10671 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIRT5 antibody, catalog no. 70R-11700 |
NAIP Blocking Peptide |
|||
33R-10672 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NAIP antibody, catalog no. 70R-11701 |
MBD2a Blocking Peptide |
|||
33R-10673 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MBD2a antibody, catalog no. 70R-11702 |
SALL1 Blocking Peptide |
|||
33R-10674 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SALL1 antibody, catalog no. 70R-11703 |
SIAH3 Blocking Peptide |
|||
33R-10675 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIAH3 antibody, catalog no. 70R-11704 |
ACAD9 Blocking Peptide |
|||
33R-10676 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACAD9 antibody, catalog no. 70R-11705 |
ACADVL Blocking Peptide |
|||
33R-10677 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADVL antibody, catalog no. 70R-11706 |
TRIM71 Blocking Peptide |
|||
33R-10678 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TRIM71 antibody, catalog no. 70R-11707 |
EZH2 Blocking Peptide |
|||
33R-10679 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EZH2 antibody, catalog no. 70R-11708 |
UPP1 Blocking Peptide |
|||
33R-1068 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PVRIG antibody, catalog no. 70R-6255 |
MyD88 Blocking Peptide |
|||
33R-10680 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MyD88 antibody, catalog no. 70R-11710 |
ACAT1 Blocking Peptide |
|||
33R-10681 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACAT1 antibody, catalog no. 70R-11711 |
ABAD Blocking Peptide |
|||
33R-10682 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ABAD antibody, catalog no. 70R-11712 |
PKB Blocking Peptide |
|||
33R-10683 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PKB antibody, catalog no. 70R-11713 |
GAI2 Blocking Peptide |
|||
33R-10684 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GAI2 antibody, catalog no. 70R-11715 |
GABP Blocking Peptide |
|||
33R-10685 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GABP antibody, catalog no. 70R-11716 |
TLR4 Blocking Peptide |
|||
33R-10686 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TLR4 antibody, catalog no. 70R-11719 |
ACAT2 Blocking Peptide |
|||
33R-10687 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACAT2 antibody, catalog no. 70R-11720 |
ERAB Blocking Peptide |
|||
33R-10688 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ERAB antibody, catalog no. 70R-11721 |
PVRIG Blocking Peptide |
|||
33R-1069 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EXOSC10 antibody, catalog no. 70R-4673 |
PARD3 Blocking Peptide |
|||
33R-10691 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PARD3 antibody, catalog no. 70R-11725 |
TCTN2 Blocking Peptide |
|||
33R-10692 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TCTN2 antibody, catalog no. 70R-11727 |
HADH Blocking Peptide |
|||
33R-10693 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HADH antibody, catalog no. 70R-11728 |
FATP4 Blocking Peptide |
|||
33R-10696 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FATP4 antibody, catalog no. 70R-11731 |
Bid Blocking Peptide |
|||
33R-10697 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Bid antibody, catalog no. 70R-11734 |
JMJD1A Blocking Peptide |
|||
33R-10698 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of JMJD1A antibody, catalog no. 70R-11735 |
RIP Blocking Peptide |
|||
33R-10699 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RIP antibody, catalog no. 70R-11737 |
EXOSC10 Blocking Peptide |
|||
33R-1070 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MKRN2 antibody, catalog no. 70R-2131 |
MBD1 Blocking Peptide |
|||
33R-10700 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MBD1 antibody, catalog no. 70R-11739 |
VENTX Blocking Peptide |
|||
33R-10702 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of VENTX antibody, catalog no. 70R-11742 |
ASC Blocking Peptide |
|||
33R-10703 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ASC antibody, catalog no. 70R-11744 |
RIP3 Blocking Peptide |
|||
33R-10704 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RIP3 antibody, catalog no. 70R-11745 |
SMAC Blocking Peptide |
|||
33R-10705 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SMAC antibody, catalog no. 70R-11747 |
RasGAP Blocking Peptide |
|||
33R-10706 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RasGAP antibody, catalog no. 70R-11749 |
TCTN3 Blocking Peptide |
|||
33R-10708 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TCTN3 antibody, catalog no. 70R-11753 |
BMF Blocking Peptide |
|||
33R-10709 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BMF antibody, catalog no. 70R-11754 |
MKRN2 Blocking Peptide |
|||
33R-1071 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of AMZ2 antibody, catalog no. 70R-9376 |
EndoG Blocking Peptide |
|||
33R-10710 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EndoG antibody, catalog no. 70R-11755 |
ILP2 Blocking Peptide |
|||
33R-10711 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ILP2 antibody, catalog no. 70R-11756 |
PUMA Blocking Peptide |
|||
33R-10712 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PUMA antibody, catalog no. 70R-11758 |
p53NIDP1 Blocking Peptide |
|||
33R-10713 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of p53NIDP1 antibody, catalog no. 70R-11759 |
POU2F1 Blocking Peptide |
|||
33R-10714 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of POU2F1 antibody, catalog no. 70R-11760 |
FasL Blocking Peptide |
|||
33R-10715 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FasL antibody, catalog no. 70R-11761 |
FAF1 Blocking Peptide |
|||
33R-10716 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FAF1 antibody, catalog no. 70R-11762 |
BI1 Blocking Peptide |
|||
33R-10717 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BI1 antibody, catalog no. 70R-11763 |
TANK Blocking Peptide |
|||
33R-10718 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TANK antibody, catalog no. 70R-11764 |
PCNA Blocking Peptide |
|||
33R-10719 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PCNA antibody, catalog no. 70R-11765 |
AMZ2 Blocking Peptide |
|||
33R-1072 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RNF32 antibody, catalog no. 70R-1166 |
ALK Blocking Peptide |
|||
33R-10723 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ALK antibody, catalog no. 70R-11769 |
CREB Blocking Peptide |
|||
33R-10725 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CREB antibody, catalog no. 70R-11772 |
COX1 Blocking Peptide |
|||
33R-10726 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of COX1 antibody, catalog no. 70R-11773 |
COX1 Blocking Peptide |
|||
33R-10727 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of COX1 antibody, catalog no. 70R-11774 |
BLCAM Blocking Peptide |
|||
33R-10728 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BLCAM antibody, catalog no. 70R-11775 |
BRCA1 Blocking Peptide |
|||
33R-10729 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BRCA1 antibody, catalog no. 70R-11776 |
RNF32 Blocking Peptide |
|||
33R-1073 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GOLGA7 antibody, catalog no. 70R-2903 |
Cadherin Blocking Peptide |
|||
33R-10730 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Cadherin antibody, catalog no. 70R-11777 |
TFPI Blocking Peptide |
|||
33R-10735 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TFPI antibody, catalog no. 70R-11785 |
Hsp90 Blocking Peptide |
|||
33R-10737 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Hsp90 antibody, catalog no. 70R-11793 |
Hsp105 Blocking Peptide |
|||
33R-10738 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Hsp105 antibody, catalog no. 70R-11794 |
HMOX1 Blocking Peptide |
|||
33R-10739 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HMOX1 antibody, catalog no. 70R-11795 |
GOLGA7 Blocking Peptide |
|||
33R-1074 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACSL5 antibody, catalog no. 70R-6556 |
HMOX2 Blocking Peptide |
|||
33R-10740 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HMOX2 antibody, catalog no. 70R-11796 |
HCAM Blocking Peptide |
|||
33R-10741 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HCAM antibody, catalog no. 70R-11797 |
BMX Blocking Peptide |
|||
33R-10742 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BMX antibody, catalog no. 70R-11799 |
BMX Blocking Peptide |
|||
33R-10743 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BMX antibody, catalog no. 70R-11800 |
A1 Blocking Peptide |
|||
33R-10744 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of A1 antibody, catalog no. 70R-11802 |
AFX Blocking Peptide |
|||
33R-10745 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of AFX antibody, catalog no. 70R-11803 |
BCL3 Blocking Peptide |
|||
33R-10746 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL3 antibody, catalog no. 70R-11804 |
BCL6 Blocking Peptide |
|||
33R-10747 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL6 antibody, catalog no. 70R-11805 |
ACSL5 Blocking Peptide |
|||
33R-1075 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CCND1 antibody, catalog no. 70R-10480 |
CETP Blocking Peptide |
|||
33R-10750 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CETP antibody, catalog no. 70R-11808 |
CCR1 Blocking Peptide |
|||
33R-10751 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CCR1 antibody, catalog no. 70R-11809 |
CCR2 Blocking Peptide |
|||
33R-10752 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CCR2 antibody, catalog no. 70R-11810 |
CCR3 Blocking Peptide |
|||
33R-10753 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CCR3 antibody, catalog no. 70R-11811 |
CXCR5 Blocking Peptide |
|||
33R-10754 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CXCR5 antibody, catalog no. 70R-11812 |
GADD153 Blocking Peptide |
|||
33R-10755 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GADD153 antibody, catalog no. 70R-11813 |
ICAM1 Blocking Peptide |
|||
33R-10756 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ICAM1 antibody, catalog no. 70R-11814 |
ILK1 Blocking Peptide |
|||
33R-10757 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ILK1 antibody, catalog no. 70R-11815 |
IRS1 Blocking Peptide |
|||
33R-10758 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of IRS1 antibody, catalog no. 70R-11816 |
eNOS Blocking Peptide |
|||
33R-10759 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of eNOS antibody, catalog no. 70R-11818 |
CCND1 Blocking Peptide |
|||
33R-1076 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CCND1 antibody, catalog no. 70R-7826 |
Neurexin Blocking Peptide |
|||
33R-10760 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Neurexin antibody, catalog no. 70R-11819 |
PAK2 Blocking Peptide |
|||
33R-10761 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PAK2 antibody, catalog no. 70R-11828 |
PAK4 Blocking Peptide |
|||
33R-10762 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PAK4 antibody, catalog no. 70R-11829 |
TLR3 Blocking Peptide |
|||
33R-10763 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TLR3 antibody, catalog no. 70R-11830 |
PAR4 Blocking Peptide |
|||
33R-10764 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PAR4 antibody, catalog no. 70R-11832 |
PDK1 Blocking Peptide |
|||
33R-10765 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PDK1 antibody, catalog no. 70R-11834 |
PKC Blocking Peptide |
|||
33R-10766 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PKC antibody, catalog no. 70R-11835 |
PKG Blocking Peptide |
|||
33R-10767 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PKG antibody, catalog no. 70R-11837 |
PMS2 Blocking Peptide |
|||
33R-10768 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PMS2 antibody, catalog no. 70R-11838 |
SOD1 Blocking Peptide |
|||
33R-10769 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SOD1 antibody, catalog no. 70R-11839 |
CCND1 Blocking Peptide |
|||
33R-1077 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ATP1B4 antibody, catalog no. 70R-6783 |
SGK Blocking Peptide |
|||
33R-10770 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SGK antibody, catalog no. 70R-11840 |
SMAD1 Blocking Peptide |
|||
33R-10771 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SMAD1 antibody, catalog no. 70R-11842 |
SMAD4 Blocking Peptide |
|||
33R-10772 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SMAD4 antibody, catalog no. 70R-11844 |
STAT2 Blocking Peptide |
|||
33R-10773 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of STAT2 antibody, catalog no. 70R-11846 |
STAT3 Blocking Peptide |
|||
33R-10774 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of STAT3 antibody, catalog no. 70R-11848 |
Het belangrijkste gedrag gerelateerd aan mensen met diabetes type 1 was ‘insuline nemen zoals vereist’ en voor mensen met diabetes type 2 was ‘het bijwonen en fascineren met gestructureerde scholingsprogramma’s’. ‘Betrokkenheid bij het stellen van samenwerkingsdoelen met patiënten’ was het belangrijkste gerangschikte gedrag met betrekking tot beroepsbeoefenaren in de gezondheidszorg voor het beheren van elke type 1- en type 2-diabetes. Voor het stoppen van diabetes type 2 was ‘interactie hebben met gezond gedrag als huishouden’ het hoogst gerangschikte gedrag van de bewoners en ‘wonen en interactie hebben met coaching voor gedragsverandering’ was het hoogst bekwame gedrag.
Conclusies Het is mogelijk om samen te werken met een verschillende groep belanghebbenden om de onderzoeksagenda voor diabetes te informeren. De erkende prioriteiten zijn mede tot stand gekomen door de belangrijkste belanghebbenden, samen met patiënten, zorgverleners en dekkingsmakers, en kan de groei van een programma voor gedragsonderzoek bij diabetes in Ierland informeren.
Het onderzoek biedt bovendien een moeizaam voorbeeld van een cursus onderzoeksprioritering met gebruikmaking van de nominale groepstechniek en erkende beperkingen, die nuttig kunnen zijn voor verschillende onderzoekers.